company background image
HLS

Healius ASX:HLS Stock Report

Last Price

AU$3.75

Market Cap

AU$2.1b

7D

-6.9%

1Y

-26.2%

Updated

14 Aug, 2022

Data

Company Financials +
HLS fundamental analysis
Snowflake Score
Valuation5/6
Future Growth0/6
Past Performance5/6
Financial Health4/6
Dividends4/6

HLS Stock Overview

Healius Limited provides facilities and support services to independent general practitioners, radiologists, and other healthcare professionals in Australia.

Healius Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Healius
Historical stock prices
Current Share PriceAU$3.75
52 Week HighAU$5.54
52 Week LowAU$3.59
Beta1.11
1 Month Change1.35%
3 Month Change-9.42%
1 Year Change-26.18%
3 Year Change27.99%
5 Year Change3.31%
Change since IPO167.86%

Recent News & Updates

Aug 02
Are Investors Undervaluing Healius Limited (ASX:HLS) By 48%?

Are Investors Undervaluing Healius Limited (ASX:HLS) By 48%?

Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Healius Limited...

Shareholder Returns

HLSAU HealthcareAU Market
7D-6.9%-3.9%0.7%
1Y-26.2%-9.0%-8.5%

Return vs Industry: HLS underperformed the Australian Healthcare industry which returned -9% over the past year.

Return vs Market: HLS underperformed the Australian Market which returned -8.5% over the past year.

Price Volatility

Is HLS's price volatile compared to industry and market?
HLS volatility
HLS Average Weekly Movement3.8%
Healthcare Industry Average Movement5.8%
Market Average Movement10.6%
10% most volatile stocks in AU Market18.1%
10% least volatile stocks in AU Market4.6%

Stable Share Price: HLS is less volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: HLS's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199411,000Malcolm Parmenterhttps://www.healius.com.au

Healius Limited provides facilities and support services to independent general practitioners, radiologists, and other healthcare professionals in Australia. The company operates through three segments: Pathology, Imaging, and Day Hospitals. It offers diagnostic imaging services, including X-ray, ultrasound, computerized tomography, mammography, magnetic resonance imaging, nuclear medicine, positron emission tomography, and interventional radiology; and private medical laboratory and pathology services.

Healius Limited Fundamentals Summary

How do Healius's earnings and revenue compare to its market cap?
HLS fundamental statistics
Market CapAU$2.14b
Earnings (TTM)AU$226.80m
Revenue (TTM)AU$2.32b

9.4x

P/E Ratio

0.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
HLS income statement (TTM)
RevenueAU$2.32b
Cost of RevenueAU$1.31b
Gross ProfitAU$1.01b
Other ExpensesAU$779.70m
EarningsAU$226.80m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

Aug 30, 2022

Earnings per share (EPS)0.40
Gross Margin43.45%
Net Profit Margin9.79%
Debt/Equity Ratio17.0%

How did HLS perform over the long term?

See historical performance and comparison

Dividends

5.3%

Current Dividend Yield

45%

Payout Ratio